Canada Life
CDLX icon

Canada Life’s Cardlytics CDLX Stock Holding History

Canada Life’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-163
Closed -$9K – 2318
2022
Q4 		$9K Hold
163
– – ﹤0.01% 2329
2022
Q3 		$15K Hold
163
– – ﹤0.01% 2297
2022
Q2 		$36K Hold
163
– – ﹤0.01% 2119
2022
Q1 		$95K Hold
163
– – ﹤0.01% 2011
2021
Q4 		$108K Hold
163
– – ﹤0.01% 1991
2021
Q3 		$138K Sell
163
-27
-14% -$27.4K ﹤0.01% 1984
2021
Q2 		$241K Buy
190
+25
+15% +$28.2K ﹤0.01% 1886
2021
Q1 		$179K Sell
165
-3,847
-96% -$5.08M ﹤0.01% 1971
2020
Q4 		$5.74M Sell
4,012
-4,619
-54% -$4.93M 0.01% 754
2020
Q3 		$6.09M Buy
8,631
+164
+2% +$119K 0.01% 657
2020
Q2 		$5.91M Sell
8,467
-3,594
-30% -$2.08M 0.01% 650
2020
Q1 		$4.23M Buy
12,061
+11,928
+8,968% +$8.45M 0.01% 677
2019
Q4 		$83K Buy
+133
New +$65K ﹤0.01% 2116

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Canada Life's CDLX Position: Q1 2023 in Review

Canada Life sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 163 shares — an estimated $9K sold.

Canada Life first reported a position in CDLX in Q4 2019 and held it in 13 quarters. The position peaked at $6.09M in Q3 2020. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Canada Life reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 163 Cardlytics shares in Q1 2023, an estimated $9K.
  • Canada Life first reported a position in Cardlytics in Q4 2019 and held it in 13 quarters.
  • Canada Life's Cardlytics position peaked at $6.09M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.